Age and comorbidity in relation to treatment and survival outcomes in triple-negative breast cancer: A Swedish nationwide registry-based study
Patients with TNBC and comorbidities are less likely to receive specific treatment modalities and experience worse survival outcomes. Other malignant neoplasms are the leading cause of death for patients ≥50 years of age.
Authors
- Jenny Nyqvist-Streng (ORCID: https://orcid.org/0000-0002-9934-8407)
- Toshima Z. Parris (ORCID: https://orcid.org/0000-0003-0834-5540)
- Maxim Olsson (ORCID: https://orcid.org/0009-0005-9832-5536)
- Chaido Chamalidou (ORCID: https://orcid.org/0000-0002-5992-537X)
- Anikó Kovács (ORCID: https://orcid.org/0000-0001-8117-6283)
- Jari Martikainen (ORCID: https://orcid.org/0000-0001-8027-2417)
- Khalil Helou
- Josef Somi
Institutions
- Sahlgrenska University Hospital (SE)
- Region Västra Götaland (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- Journal of Geriatric Oncology
- Published
- 2025-05-08
- DOI
- https://doi.org/10.1016/j.jgo.2025.102255
- Citations
- 2
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.87
Funders
- Åke Wiberg Stiftelse
- Insamlingsstiftelsen Cancer- och Allergifonden
- Göteborgs Universitet
- Magnus Bergvalls Stiftelse
- Stiftelsen Jubileumsklinikens Forskningsfond mot Cancer